Alcon (ALC) Liabilities and Shareholders Equity (2009 - 2026)
Alcon (ALC) posted quarterly Liabilities and Shareholders Equity of $31.6 billion for Q1 2026, little changed quarter-over-quarter from $31.6 billion in Q4 2025.
Alcon (ALC) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Alcon's Liabilities and Shareholders Equity history runs 11 years deep, the most recent figure standing at $31.6 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $31.6 billion; the TTM figure through Mar 2026 stood at $126.1 billion (up 39.43% YoY), while the FY2025 annual figure was $31.6 billion, up 3.98% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $31.6 billion, roughly flat from $31.6 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $31.6 billion in Q1 2026, with the low at $27.7 billion in Q2 2022.
- The 5-year median for Liabilities and Shareholders Equity is $29.6 billion (2023), against an average of $29.8 billion.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity declined 0.08% in 2022, then rose 5.66% in 2023.
- Alcon's Liabilities and Shareholders Equity stood at $29.2 billion in 2022, then advanced by 1.54% to $29.6 billion in 2023, then advanced by 2.48% to $30.3 billion in 2024, then grew by 3.98% to $31.6 billion in 2025, then increased by 0.2% to $31.6 billion in 2026.
- Business Quant data shows ALC's Liabilities and Shareholders Equity at $31.6 billion in Q1 2026, $31.6 billion in Q4 2025, and $31.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 6.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.10 Bn |
| Mar 31, 2026 | 31.62 Bn |
| Dec 31, 2025 | 31.56 Bn |
| Sep 30, 2025 | 31.52 Bn |
| Jun 30, 2025 | 31.39 Bn |
| Dec 31, 2024 | 30.35 Bn |
| Sep 30, 2024 | 30.36 Bn |
| Jun 30, 2024 | 29.72 Bn |
| Mar 31, 2024 | 29.57 Bn |
| Dec 31, 2023 | 29.61 Bn |
| Sep 30, 2023 | 29.37 Bn |
| Jun 30, 2023 | 29.21 Bn |
| Mar 31, 2023 | 29.29 Bn |
| Dec 31, 2022 | 29.17 Bn |
| Sep 30, 2022 | 27.80 Bn |
| Jun 30, 2022 | 27.73 Bn |
| Mar 31, 2022 | 27.79 Bn |
| Dec 31, 2021 | 28.00 Bn |
| Sep 30, 2021 | 27.80 Bn |
| Jun 30, 2021 | 27.75 Bn |